Marfan Syndrome
Overview
Plain-Language Overview
Marfan Syndrome is a genetic disorder that affects the body's connective tissue, which provides strength and flexibility to structures like the heart, blood vessels, bones, and eyes. People with this condition often have a tall and slender build with long arms, legs, fingers, and toes. The disorder mainly impacts the cardiovascular system, especially the aorta, which can become enlarged and prone to tearing, posing serious health risks. It also affects the skeletal system, causing abnormalities such as a curved spine or chest deformities. Eye problems like lens dislocation are common. Because connective tissue is widespread, Marfan Syndrome can affect many parts of the body, leading to a variety of symptoms and complications.
Clinical Definition
Marfan Syndrome is an autosomal dominant connective tissue disorder caused primarily by mutations in the FBN1 gene encoding fibrillin-1, a critical component of microfibrils in the extracellular matrix. This leads to defective connective tissue integrity and abnormal regulation of transforming growth factor-beta (TGF-β) signaling. The disorder is characterized by skeletal abnormalities such as arachnodactyly, pectus deformities, and scoliosis; ocular manifestations including ectopia lentis; and cardiovascular complications like aortic root dilation, aneurysm, and dissection, which are the leading causes of morbidity and mortality. Diagnosis relies on clinical criteria supported by family history and genetic testing. The systemic nature of the disease requires multidisciplinary management to monitor and address progressive complications.
Inciting Event
There is no specific external trigger; disease results from inherited or spontaneous FBN1 mutations.
Progressive aortic root dilation may be precipitated by normal hemodynamic stress over time.
Mechanical stress on weakened connective tissue can lead to acute aortic dissection.
Latency Period
Symptoms often develop gradually during childhood or adolescence as connective tissue abnormalities progress.
Aortic complications may not present until adulthood despite earlier skeletal or ocular signs.
Latency between genetic mutation and clinical diagnosis can span years to decades.
Diagnostic Delay
Variable expressivity and subtle early signs often lead to misdiagnosis or under-recognition.
Overlap with other connective tissue disorders such as Ehlers-Danlos syndrome can confuse diagnosis.
Lack of awareness of family history or incomplete clinical evaluation delays diagnosis.
Mild or isolated skeletal features may be attributed to normal variation, causing delayed referral.
Clinical Presentation
Signs & Symptoms
Visual disturbances due to ectopia lentis or myopia
Chest pain or dyspnea from cardiovascular involvement
Joint pain or frequent dislocations due to joint hypermobility
Fatigue and decreased exercise tolerance
Palpitations or symptoms of heart failure from valvular disease
History of Present Illness
Patients commonly report tall stature with long limbs and fingers (arachnodactyly) progressing over years.
Visual symptoms such as blurred vision or lens dislocation may develop in adolescence or early adulthood.
Cardiovascular symptoms like chest pain or palpitations may indicate aortic root dilation or dissection.
History often includes joint hypermobility, scoliosis, or pectus deformities noted since childhood.
Past Medical History
Previous diagnosis of ectopia lentis or myopia may be present.
History of spontaneous pneumothorax can occur due to lung connective tissue fragility.
Prior cardiac surgery or monitoring for aortic dilation may be documented.
Skeletal abnormalities such as scoliosis or pectus excavatum often noted in childhood.
Family History
A positive family history of Marfan syndrome or sudden cardiac death is common due to autosomal dominant inheritance.
Relatives may have aortic aneurysms, lens dislocation, or tall stature with skeletal abnormalities.
Some cases arise from de novo FBN1 mutations with no prior family history.
Family history of early-onset aortic dissection or valve disease should raise suspicion.
Physical Exam Findings
Tall stature with disproportionately long limbs and fingers (arachnodactyly)
Pectus excavatum or pectus carinatum chest deformities
Scoliosis or other spinal abnormalities
Ectopia lentis (dislocation of the ocular lens)
Hypermobile joints with increased range of motion
High-arched palate and dental crowding
Diagnostic Workup
Diagnostic Criteria
Diagnosis is established using the Ghent criteria, which emphasize the presence of aortic root dilation or dissection and ectopia lentis as major criteria. Additional systemic features such as skeletal abnormalities, skin striae, and family history contribute to the diagnosis. Identification of a pathogenic FBN1 mutation confirms the diagnosis. Echocardiography is essential to assess aortic root size, and slit-lamp examination detects lens dislocation. The criteria integrate clinical, imaging, and genetic findings to differentiate Marfan syndrome from related connective tissue disorders.
Pathophysiology
Key Mechanisms
Mutations in the FBN1 gene cause defective fibrillin-1, leading to weakened connective tissue integrity.
Dysregulation of transforming growth factor-beta (TGF-β) signaling contributes to abnormal extracellular matrix remodeling.
Structural weakness in the aortic media predisposes to aortic root dilation and aneurysm formation.
Defective connective tissue causes lens dislocation due to weakened zonular fibers.
Skeletal manifestations arise from abnormal microfibril formation affecting bone growth and joint laxity.
| Involvement | Details |
|---|---|
| Organs | Aorta is commonly affected with progressive dilation of the aortic root and risk of dissection. |
Eye involvement includes lens dislocation (ectopia lentis) due to weakened zonular fibers. | |
Skeletal system shows abnormalities such as arachnodactyly, pectus deformities, and scoliosis. | |
| Tissues | Connective tissue is structurally weakened due to defective fibrillin-1 microfibrils, leading to systemic manifestations. |
Aortic media tissue is prone to cystic medial necrosis causing aneurysm and dissection. | |
| Cells | Fibroblasts produce defective fibrillin-1 leading to abnormal connective tissue matrix in Marfan syndrome. |
Smooth muscle cells in the aortic media are affected by abnormal extracellular matrix causing weakening and dilation. | |
| Chemical Mediators | Fibrillin-1 is a key extracellular matrix protein mutated in Marfan syndrome causing defective microfibrils. |
Transforming growth factor-beta (TGF-beta) signaling is upregulated and contributes to connective tissue degradation and aortic aneurysm formation. |
Treatments
Pharmacological Treatments
Beta blockers
- Mechanism:
Reduce aortic wall stress by decreasing heart rate and blood pressure, slowing aortic root dilation.
- Side effects:
Bradycardia
Fatigue
Hypotension
- Clinical role:
First-line
Angiotensin II receptor blockers (ARBs)
- Mechanism:
Block angiotensin II receptors to reduce TGF-beta signaling and aortic root dilation.
- Side effects:
Hyperkalemia
Hypotension
Renal impairment
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Regular cardiovascular monitoring with echocardiography to assess aortic root size and valve function.
Avoidance of strenuous physical activity and contact sports to reduce risk of aortic dissection.
Elective surgical repair of the aortic root when dilation exceeds threshold size or rapid growth occurs.
Prevention
Pharmacological Prevention
Beta-blockers to reduce aortic wall stress and slow dilation
Angiotensin receptor blockers (ARBs) as an alternative to beta-blockers
Regular use of antihypertensives to maintain optimal blood pressure
Prophylactic antibiotics before dental or surgical procedures if valvular disease is present
Avoidance of medications that increase heart rate or blood pressure
Non-pharmacological Prevention
Regular cardiovascular imaging to monitor aortic size and valve function
Activity modification to avoid strenuous or contact sports that increase aortic stress
Genetic counseling for affected individuals and family members
Early surgical intervention for significant aortic root dilation
Ophthalmologic monitoring to detect and manage lens dislocation early
Outcome & Complications
Complications
Aortic dissection leading to life-threatening hemorrhage
Severe mitral or aortic valve regurgitation causing heart failure
Retinal detachment from ocular involvement
Spontaneous pneumothorax due to lung cysts
Dural ectasia causing neurological deficits
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Marfan Syndrome versus Ehlers-Danlos Syndrome (EDS)
Marfan Syndrome | Ehlers-Danlos Syndrome (EDS) |
|---|---|
Typically autosomal dominant inheritance due to FBN1 mutations | Most forms are inherited in an autosomal dominant pattern, but some types are autosomal recessive |
Mutation in FBN1 causing defective fibrillin-1 affecting connective tissue microfibrils | Defects in collagen synthesis or structure with abnormal collagen on skin biopsy |
Aortic root dilation and ectopia lentis are common imaging findings | Joint hypermobility and skin hyperextensibility without significant aortic root dilation |
Progressive aortic aneurysm and dissection risk with systemic skeletal and ocular involvement | Primarily presents with skin fragility, easy bruising, and joint hypermobility without major cardiovascular complications in most types |
Marfan Syndrome versus Loeys-Dietz Syndrome
Marfan Syndrome | Loeys-Dietz Syndrome |
|---|---|
Autosomal dominant mutations in FBN1 gene | Autosomal dominant mutations in TGFBR1 or TGFBR2 genes |
Primarily aortic root dilation and aneurysms without widespread arterial tortuosity | Widespread arterial tortuosity and aneurysms including craniofacial arteries |
Defective fibrillin-1 microfibrils leading to altered TGF-beta regulation | Elevated TGF-beta signaling markers |
Characteristic ectopia lentis and tall stature with arachnodactyly | Distinctive craniofacial abnormalities such as hypertelorism and bifid uvula |
Marfan Syndrome versus Homocystinuria
Marfan Syndrome | Homocystinuria |
|---|---|
Autosomal dominant disorder due to FBN1 mutation | Autosomal recessive disorder due to CBS deficiency |
Normal intellect and aortic aneurysm risk without thromboembolism | Intellectual disability and thromboembolic events common |
Superotemporal lens dislocation | Inferonasal lens dislocation |
No homocysteine elevation; diagnosis by FBN1 mutation analysis | Elevated plasma homocysteine and methionine levels |
Marfan Syndrome versus Shprintzen-Goldberg Syndrome
Marfan Syndrome | Shprintzen-Goldberg Syndrome |
|---|---|
Autosomal dominant mutations in FBN1 gene | Autosomal dominant mutations in SKI gene |
Normal intellect with marfanoid habitus and no craniosynostosis | Craniosynostosis and intellectual disability prominent |
Aortic root dilation with ectopia lentis but no craniosynostosis | Aortic root dilation with craniofacial abnormalities |
Marfan Syndrome versus Ectopia Lentis Syndrome (Isolated)
Marfan Syndrome | Ectopia Lentis Syndrome (Isolated) |
|---|---|
Autosomal dominant with FBN1 mutations | Often autosomal dominant with mutations in ADAMTSL4 |
Ectopia lentis plus systemic skeletal and cardiovascular manifestations | Isolated ectopia lentis without systemic features |
Progressive aortic root dilation and skeletal deformities | No progressive aortic root dilation or skeletal abnormalities |